Whole-Exome Sequencing Reveals Defective <i>CYP3A4</i> Variants Predictive of Paclitaxel Dose-Limiting Neuropathy
María Apellániz-Ruiz(Navarrabiomed), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Jesús García-Donás(Universidad San Pablo CEU), Magnus Ingelman‐Sundberg(Karolinska Institutet), María Sereno(Hospital Universitario Infanta Sofía), Lara M. Munín Sánchez(Spanish National Cancer Research Centre), Isabel Calvo(Centro Oncológico de Galicia), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Laura García‐Estévez(MD Anderson Cancer Center Madrid), Miyoung Lee(Emory University), Inger Johansson(Sahlgrenska University Hospital), Alberto Cascón(Spanish National Cancer Research Centre), Beatriz Castelo, Gerardo Gutiérrez‐Gutiérrez(Erasmus University Rotterdam), Eva Guerra(Hospital Universitario Ramón y Cajal), Luis J. Leandro‐García(Spanish National Cancer Research Centre)
Cited by 72
Related Papers
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508